Latest rulings

  • Menwell Ltd t/a Voy

    • Upheld
    • Email
    • 27 May 2026

    Three emails for an online pharmacy promoted prescription-only medicines to the public against the law and our rules. The ads were also socially irresponsible by creating an undue sense of urgency for people who were considering medicated weight-loss programmes. 

  • GLP-1 Pro Ltd t/a GuLP-1

    • Upheld
    • 06 May 2026

    Two webpages for a food supplement company made claims that a supplement could prevent, treat or cure human disease and made unauthorised health and medicinal claims. The ads also compared the effects of a food supplement to those associated with weight-loss prescr...

  • Medilife Clinic Enfield

    • Upheld
    • Social media (paid ad)
    • 06 May 2026

    A paid-for Instagram ad for a health clinic made claims that their treatments could alleviate or treat the traits of autism without suitable evidence to support these claims. The ad also discouraged essential treatment for conditions for which medical supervision should be sought. 

  • Juniper Technologies UK Ltd t/a Juniper

    • Upheld
    • Social media (influencer or affiliate ad)
    • 08 April 2026

    Posts in weight-loss support groups on Facebook didn't make clear they were paid for by the advertiser and they promoted prescription-only medicines to the public, which is against the law and our rules.